Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Lidocaine Spray as Adjuvant to Upper GI Endoscopy in Children
NCT00521703Phase 3Completed
- Sponsor
- Hospital Infantil Cândido Fontoura
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in dyspepsia, malabsorption syndrome, gastroesophageal reflux disease (GERD) and 1 more, sponsored by Hospital Infantil Cândido Fontoura. Primary endpoint: propofol dose required to achieve adequate sedation at 1 hour. Started Aug 2007; status: completed.
02
Drugs
lidocaine
03
Conditions
dyspepsiamalabsorption syndromegastroesophageal reflux disease (GERD)abdominal pain
Beyond the preview
Go deeper on NCT00521703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521703.